Sirolimus protein-bound particles inotenderwa kune yakaipa perivascular epithelioid cell bundu

Share This Post

Jan 2022: Kune varwere vakura vane nharaunda yepamusoro isinga gadziriswe kana metastatic malignant perivascular epithelioid cell tumours, iyo Food and Drug Administration inopihwa rezinesi. sirolimus mapuroteni-akasungwa zvidimbu zvejekiseni kumiswa (albumin-yakasungwa) (Fyarro, Aadi Bioscience, Inc.) (PEComa).

Kubudirira kwakaedzwa muvarwere ve31 vane nzvimbo yepamusoro isingagadziriswi kana metastatic yakashata PEComa mu AMPECT (NCT02494570), yakawanda, imwe-ruoko rwekliniki yekudzidza. Pamazuva 1 uye 8 ega ega 21-zuva kutenderera, varwere vakagamuchira 100 mg/m2 sirolimus mapuroteni-akasungwa particles kusvikira kufambira mberi kwechirwere kana kusashivirira chepfu.

Kuwanda kwekupindura kwehuwandu (ORR) uye nguva yekupindura (DOR) ndiyo yakakosha yemigumisiro yemigumisiro, sezvakatsanangurwa neyakapofumadzwa yakazvimirira central review uchishandisa RECIST v.1.1. IORR yaiva 39 muzana (95 muzana CI: 22 muzana, 58 muzana), nevarwere vaviri vachipindura zvakakwana. Iyo yepakati DOR haina kusangana (95 muzana CI: 6.5 mwedzi, isingafungidzirwe). 67 muzana yevakapindura vane mhinduro yakatora mwedzi inopfuura 12, uye 58 muzana yakanga ine mhinduro yakatora mwedzi inopfuura 24.

Stomatitis, kuneta, mapundu, utachiona, kuda kurutsa, edoema, manyoka, kusagadzikana kwemisuloskeletal, kuderera kwehuremu, kuderera kwechido, kukosora, kurutsa, uye dysgeusia ndizvo zvaive zvakanyanya kuitika (30 muzana). Kuderera kwe lymphocyte, glucose yakawedzera, potassium yakaderera, yakaderera phosphate, yakadzikira haemoglobin, uye yakakwira lipase ndiyo yainyanya kupararira giredhi 3 kusvika 4 rabhoritari abnormalities (6%).

Kusvikira kufambira mberi kwechirwere kana huturu husingagoneki, iyo inokurudzirwa dosage i100 mg/m2 yakapihwa seIV infusion pamusoro pe30 maminetsi pamazuva 1 uye 8 ega ega 21-zuva kutenderera.

 

Click this link for full prescribing information for Fyarro.

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Kurapa Kwemasero eCAR T kunoitwa nevanhu: Kubudirira Uye Zvinetso
CAR T-Cell kurapa

Kurapa Kwemasero eCAR T: Kubudirira uye Zvinetso

Human-based CAR T-cell therapy inosandura kurapwa kwegomarara nekugadzirisa magene masero emuviri emurwere kuti anange nekuparadza maseru egomarara. Nekushandisa simba rekudzivirira kwemuviri, marapirwo aya anopa marapiro ane simba uye emunhu ane mukana wekuregererwa kwenguva refu mumhando dzakasiyana dzegomarara.

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa
CAR T-Cell kurapa

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa

Cytokine Release Syndrome (CRS) is immune system reaction inowanzo kukonzerwa nemamwe marapirwo senge immunotherapy kana CAR-T cell therapy. Zvinosanganisira kuburitswa kwakanyanya kwemacytokines, zvichikonzera zviratidzo kubva pafivha uye kuneta kusvika kune zvinogona kuuraya hupenyu sekukuvadzwa kwenhengo. Kutungamira kunoda kunyatsotarisisa uye nzira dzekupindira.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa